Actively Recruiting
A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
Led by Guangzhou Medical University · Updated on 2025-04-27
1000
Participants Needed
2
Research Sites
226 weeks
Total Duration
On this page
AI-Summary
What this Trial Is About
This is a retrospective and prospective study planned to include NSCLC patients with Leptomeningeal metastasis (LM) and treated with antitumor therapy after 2018, from multiple centers such as the First Affiliated Hospital of Guangzhou Medical University, Guangdong Sanjiu Brain Hospital, etc., aiming to establish a database related to the treatment strategies of LM patients, and to evaluate the efficacy (eg. Overall Survival/Time to Failure) and safety of different treatment strategies of LM patients, etc., as well as the significance of concomitant testing in LM patients.
CONDITIONS
Official Title
A Real-world Study on the Treatment of Non-small Cell Lung Cancer With Leptomeningeal Metastasis in China
Who Can Participate
Eligibility Criteria
You may qualify if you...
- Non-small cell lung cancer patients with leptomeningeal metastases diagnosed after January 2018
- Patients who underwent antitumor therapy after diagnosis of leptomeningeal metastasis
You will not qualify if you...
- Patients with small cell lung cancer components
- Patients with tumors other than non-small cell lung cancer
AI-Screening
AI-Powered Screening
Complete this quick 3-step screening to check your eligibility
Trial Site Locations
Total: 2 locations
1
Guangdong Sanjiu Brain Hospital
Guangzhou, Guangdong, China, 510000
Actively Recruiting
2
the First Affiliated Hospital of Guangzhou Medical University
Guangzhou, Guangdong, China, 510120
Actively Recruiting
Research Team
H
hong hai Yang
CONTACT
How is the study designed?
Study Type
OBSERVATIONAL
Masking
N/A
Allocation
N/A
Model
N/A
Primary Purpose
N/A
Number of Arms
0
Not the Right Trial for You?
Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.
Already have an account? Log in here